WWM
DOVA

Willingdon Wealth Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Willingdon Wealth Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11
Closed – – 575
2019
Q3 		$0 Buy
+11
New +$178 ﹤0.01% 558

Willingdon Wealth Management's DOVA Position: Q4 2019 in Review

Willingdon Wealth Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 11 shares.

Willingdon Wealth Management first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Willingdon Wealth Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Willingdon Wealth Management sold 11 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019.
  • Willingdon Wealth Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Willingdon Wealth Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Willingdon Wealth Management's 13F filing for Q4 2019, filed 10 Feb 2020.